Comparison of plasma and <scp>CSF</scp> biomarkers in predicting cognitive decline-Reference-Cited by-同舟云学术

Comparison of plasma and CSF biomarkers in predicting cognitive decline

Published:2022-10-02 Issue:11 Volume:9 Page:1739-1751
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Aschenbrenner Andrew J.¹²^ORCID,Li Yan²³,Henson Rachel L.¹²,Volluz Katherine¹²,Hassenstab Jason¹²,Verghese Philip⁴,West Tim⁴,Meyer Matthew R.⁴,Kirmess Kristopher M.⁴,Fagan Anne M.¹²⁵,Xiong Chengjie²³,Holtzman David¹²⁵,Morris John C.¹²⁵,Bateman Randall J.¹²⁵,Schindler Suzanne E.¹²

Affiliation:

1. Department of Neurology Washington University School of Medicine St. Louis MO USA

2. Knight Alzheimer Disease Research Center Washington University School of Medicine St. Louis MO USA

3. Division of Biostatistics Washington University School of Medicine St. Louis MO USA

4. C2N Diagnostics St. Louis MO USA

5. Hope Center for Neurological Disorders Washington University School of Medicine St. Louis MO USA

Funder

National Institute on Aging

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51670

Reference53 articles.

1. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

2. Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease

3. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

4. Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study

5. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A non-targeting magnetic metal-organic framework probe for highly specific peptide-mediated precise disease monitoring;Talanta;2024-07

2. Which neuroimaging and fluid biomarkers method is better in theranostic of Alzheimer’s disease? An umbrella review;IBRO Neuroscience Reports;2024-06

3. Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients;Alzheimer's Research & Therapy;2024-05-16

4. Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank;BMC Medicine;2024-05-13

5. Correlation between sarcopenia index and cognitive function in older adult women: A cross-sectional study using NHANES data;Journal of Clinical Neuroscience;2024-04